AstraZeneca is considering moving its stock market listing from London, where it is the exchange's most valuable company, to ...

AstraZeneca Plc’s shares rose after a report that Chief Executive Officer Pascal Soriot wants to move the British drugmaker’s ...

Just days after President Donald Trump was elected in November, AstraZeneca unvei | AstraZeneca CEO Pascal Soriot is plotting ...

The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...

That morning, U.K. newspaper The Times published an article stating that AstraZeneca CEO Pascal Soriot aims to move the company's stock market listing onto our shores (ADSes are certificates ...

AstraZeneca’s chief executive has discussed quitting Britain in a move that would deal a significant blow to the City of ...

AstraZeneca chief executive Pascal Soriot is considering moving the company's stock exchange listing from the UK to the US – ...

The biopharmaceutical giant AstraZeneca is considering moving their stock listing from the London Stock Exchange to the US in ...

--AstraZeneca's chief executive is considering moving its listing from London to the U.S. due to U.K. restrictions on medicines and pricing, The Times reports, citing unnamed sources. --Pascal ...

(Reuters) -AstraZeneca CEO Pascal Soriot is considering moving the company's stock market listing to the U.S., the Times ...

Sky's James Sillars writes that a government, struggling for authority and prioritising economic growth, can not afford to ...

CEO Pascal Soriot has privately expressed a preference to shift AstraZeneca's listing on multiple occasions and has also discussed relocating the company's domicile, the Times said. AstraZeneca ...